Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Kazushige, Futsuhara"'
Autor:
Shota Fukai, Yuki Mizusawa, Hiroshi Noda, Shingo Tsujinaka, Yukihisa Maeda, Ryuji Hasebe, Yusuke Eguchi, Rina Kanemitsu, Natsumi Matsuzawa, Iku Abe, Yuhei Endo, Taro Fukui, Yuji Takayama, Kosuke Ichida, Koetsu Inoue, Yuta Muto, Fumiaki Watanabe, Kazushige Futsuhara, Yasuyuki Miyakura, Toshiki Rikiyama
Publikováno v:
Trials, Vol 25, Iss 1, Pp 1-11 (2024)
Abstract Background The recent guidelines from the European and American Hernia Societies recommend a continuous small-bite suturing technique with slowly absorbable sutures for fascial closure of midline abdominal wall incisions to reduce the incide
Externí odkaz:
https://doaj.org/article/9f4dc7c1177a416db3c0d16c1fee2b16
Autor:
Fumiaki Watanabe, Koichi Suzuki, Sawako Tamaki, Iku Abe, Yuhei Endo, Yuji Takayama, Hideki Ishikawa, Nao Kakizawa, Masaaki Saito, Kazushige Futsuhara, Hiroshi Noda, Fumio Konishi, Toshiki Rikiyama
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
Abstract Despite the acceptance of carbohydrate antigen 19-9 (CA19-9) as a valuable predictor for the prognosis of pancreatic ductal adenocarcinoma (PDAC), its cutoff value remains controversial. Our previous study showed a significant correlation be
Externí odkaz:
https://doaj.org/article/b2d97dda8251411abcf2742768d7823b
Autor:
Taro Fukui, Koichi Suzuki, Sawako Tamaki, Iku Abe, Yuhei Endo, Hideki Ishikawa, Nao Kakizawa, Fumiaki Watanabe, Masaaki Saito, Shingo Tsujinaka, Kazushige Futsuhara, Yasuyuki Miyakura, Hiroshi Noda, Toshiki Rikiyama
Publikováno v:
Surgical Case Reports, Vol 5, Iss 1, Pp 1-6 (2019)
Abstract Background Anti-epidermal growth factor receptor (EGFR) antibody is widely used for the treatment of patients with metastatic colorectal cancer. Hypomagnesemia is a comparatively frequent adverse event of this drug, which is likely overlooke
Externí odkaz:
https://doaj.org/article/381a49e2885a4319bb6e4beddc17fb99
Autor:
Kohei Hamamoto, Kazushige Futsuhara, Emiko Chiba, Katsuhiko Matsuura, Maya Oishi, Noriko Oyama-Manabe
Publikováno v:
Respiratory Medicine Case Reports, Vol 31, Iss , Pp 101311- (2020)
A 52-year-old woman with right-sided breast cancer was diagnosed with a left pulmonary arteriovenous malformation (PAVM) by computed tomography (CT). Percutaneous embolization of the PAVM after treatment of the breast cancer was scheduled to prevent
Externí odkaz:
https://doaj.org/article/2c94e65854f843f08a4a7ff45f88e5bd
Autor:
Fumiaki Watanabe, Koichi Suzuki, Sawako Tamaki, Iku Abe, Yuhei Endo, Yuji Takayama, Hideki Ishikawa, Nao Kakizawa, Masaaki Saito, Kazushige Futsuhara, Hiroshi Noda, Fumio Konishi, Toshiki Rikiyama
Publikováno v:
PLoS ONE, Vol 14, Iss 12, p e0227366 (2019)
BACKGROUND:Liquid biopsies enable the detection of circulating tumor DNA (ctDNA). However, the clinical significance of KRAS-mutated ctDNA for pancreatic cancer has been inconsistent with respect to its prognostic and predictive potential. METHODS AN
Externí odkaz:
https://doaj.org/article/87fb5ae3f5c04c9099b439ce12eca858
Autor:
Sawako, Tamaki, Hideki, Ishikawa, Koichi, Suzuki, Yasuaki, Kimura, Ryo, Maemoto, Iku, Abe, Yuhei, Endo, Nao, Kakizawa, Fumiaki, Watanabe, Kazushige, Futsuhara, Masaaki, Saito, Shingo, Tsujinaka, Yasuyuki, Miyakura, Toshiki, Rikiyama
Publikováno v:
Molecular and Clinical Oncology. 16
Combined treatment with bevacizumab and trifluridine/tipiracil (TAS-102) leads to an increased chance of survival in patients with refractory metastatic colorectal cancer (mCRC); however, this treatment is associated with an increased frequency of se
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::044d8fa8c17a1e0069d4bd769200650f
https://doi.org/10.3892/mco.2022.2536
https://doi.org/10.3892/mco.2022.2536
Autor:
Yuhei Endo, Koichi Suzuki, Yasuaki Kimura, Sawako Tamaki, Hidetoshi Aizawa, Iku Abe, Fumiaki Watanabe, Takaharu Kato, Masaaki Saito, Kazushige Futsuhara, Hiroshi Noda, Fumio Konishi, Toshiki Rikiyama
Publikováno v:
International journal of oncology. 60(6)
Genome‑wide DNA hypomethylation is the most common molecular feature in human cancers associated with chromosomal instability (CIN), which is involved in the mechanisms that regulate pancreatic cancer (PC) metastasis. It was investigated whether ge
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8ac373c013ad70fc35fda03c713b400
https://pubmed.ncbi.nlm.nih.gov/35419613
https://pubmed.ncbi.nlm.nih.gov/35419613
Autor:
Hideki Ishikawa, Toshiki Rikiyama, Nao Kakizawa, Fumio Konishi, Iku Abe, Yuhei Endo, Hiroshi Noda, Yuji Takayama, Sawako Tamaki, Masaaki Saito, Koichi Suzuki, Kazushige Futsuhara, Fumiaki Watanabe
Publikováno v:
Scientific Reports
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
Despite the acceptance of carbohydrate antigen 19-9 (CA19-9) as a valuable predictor for the prognosis of pancreatic ductal adenocarcinoma (PDAC), its cutoff value remains controversial. Our previous study showed a significant correlation between CA1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38abb6e748aadaa05fc41ca1f06db5f6
https://doi.org/10.21203/rs.3.rs-568196/v1
https://doi.org/10.21203/rs.3.rs-568196/v1
Autor:
Yasuo Yamazaki, Kei Kimizuka, Hirofumi Yamada, Takashi Sakurai, Kazushige Futsuhara, Toru Kuroda, Masato Kojima, Sbccsg investigators, Kenichi Inoue, Shigenori Nagai, Satoshi Hata, Tsuyoshi Saito
Publikováno v:
Investigational New Drugs
Summary Purpose We examined the feasibility, efficacy, and safety of TS-1 add-on therapy (TAT) in Japanese patients with triple-negative breast caner (TNBC). Methods TAT (TS-1, 80 mg/m2/day, BID, PO), consisting of the 21-day cycles of 14-day consecu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6c8161fcbebeb16bde9c2032057b82a
http://europepmc.org/articles/PMC6985043
http://europepmc.org/articles/PMC6985043
Autor:
Kazushige Futsuhara, Tsuyoshi Saito, Shiori Kaneko, Kenichi Inoue, Satoshi Hata, Satoko Nakano, Takashi Sakurai, Hirofumi Yamada, Masafumi Kurosumi, Kei Kimizuka, Shigenori Nagai
Publikováno v:
Journal of Nippon Medical School. 86:165-171
Background Fulvestrant 500 mg has been an option for endocrine therapy for advanced or recurrent breast cancer after prior endocrine treatment since November 2011 in Japan. This study aimed to clarify the effectiveness and safety of fulvestrant 500 m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d473edcd9ebef9f5e991aa9acbedcb3
https://doi.org/10.1272/jnms.jnms.2019_86-305
https://doi.org/10.1272/jnms.jnms.2019_86-305